1. Home
  2. INZY vs AOUT Comparison

INZY vs AOUT Comparison

Compare INZY & AOUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INZY
  • AOUT
  • Stock Information
  • Founded
  • INZY 2015
  • AOUT 2020
  • Country
  • INZY United States
  • AOUT United States
  • Employees
  • INZY N/A
  • AOUT N/A
  • Industry
  • INZY Biotechnology: Pharmaceutical Preparations
  • AOUT Ordnance And Accessories
  • Sector
  • INZY Health Care
  • AOUT Industrials
  • Exchange
  • INZY Nasdaq
  • AOUT Nasdaq
  • Market Cap
  • INZY 188.2M
  • AOUT 195.7M
  • IPO Year
  • INZY 2020
  • AOUT N/A
  • Fundamental
  • Price
  • INZY $1.36
  • AOUT $17.10
  • Analyst Decision
  • INZY Strong Buy
  • AOUT Strong Buy
  • Analyst Count
  • INZY 8
  • AOUT 2
  • Target Price
  • INZY $17.75
  • AOUT $15.50
  • AVG Volume (30 Days)
  • INZY 1.0M
  • AOUT 75.1K
  • Earning Date
  • INZY 03-11-2025
  • AOUT 03-06-2025
  • Dividend Yield
  • INZY N/A
  • AOUT N/A
  • EPS Growth
  • INZY N/A
  • AOUT N/A
  • EPS
  • INZY N/A
  • AOUT N/A
  • Revenue
  • INZY N/A
  • AOUT $201,598,000.00
  • Revenue This Year
  • INZY N/A
  • AOUT $5.63
  • Revenue Next Year
  • INZY N/A
  • AOUT $6.85
  • P/E Ratio
  • INZY N/A
  • AOUT N/A
  • Revenue Growth
  • INZY N/A
  • AOUT 3.66
  • 52 Week Low
  • INZY $1.24
  • AOUT $7.45
  • 52 Week High
  • INZY $7.80
  • AOUT $17.91
  • Technical
  • Relative Strength Index (RSI)
  • INZY 29.28
  • AOUT 57.01
  • Support Level
  • INZY $1.35
  • AOUT $16.33
  • Resistance Level
  • INZY $1.62
  • AOUT $17.91
  • Average True Range (ATR)
  • INZY 0.13
  • AOUT 0.87
  • MACD
  • INZY 0.04
  • AOUT -0.09
  • Stochastic Oscillator
  • INZY 32.89
  • AOUT 57.00

About INZY Inozyme Pharma Inc.

Inozyme Pharma Incclinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company is pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 Deficiencies. The company product candidate, INZ-701, is a soluble, recombinant, genetically engineered, fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 Deficiencies.

About AOUT American Outdoor Brands Inc.

American Outdoor Brands Inc is engaged in the business of providing outdoor products and accessories for hunting, fishing, camping, shooting, and personal security and defense products. The company designs and produces products and accessories, including shooting supplies, rest, vaults, and other related accessories; premium sportsman knives and tools for fishing and hunting; land management tools for hunting preparedness; harvesting products for post-hunt or post-fishing activities; electro-optical devices, including hunting optics, firearm aiming devices, flashlights, and laser grips; reloading, gunsmithing, and firearm cleaning supplies; and survival, camping, and emergency preparedness products.

Share on Social Networks: